New and Investigational Antiretroviral Drugs
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Resource from the RWHAP Best Practices Compilation updated on 02/12/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource from the RWHAP Best Practices Compilation updated on 04/18/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource updated 01/31/2023
Resource from the RWHAP Best Practices Compilation updated on 01/03/2024
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Resource from the RWHAP Best Practices Compilation updated on 04/01/2024
Resource from the RWHAP Best Practices Compilation updated on 02/20/2024
Resource from the RWHAP Best Practices Compilation updated on 02/12/2024
Resource updated 04/07/2023
Resource (Conference Presentation) updated 09/14/2023
Resource (Conference Presentation) updated 09/14/2023
Discussion of the SPNS Black MSM Initiatives challenges and solutions to addressing program and client engagement disruptions.
Resource (Conference Presentation) updated 09/14/2023
Outreach strategies to better serve rural MSM populations impacted by cultural, geographic, and resource-related barriers to HIV testing.
Resource (Conference Presentation) updated 09/14/2023
Overview of the policies, procedures, and protocols developed by an ADAP and Part C clinic to establish access to antiretrovirals, including long-acting cabotegravir/rilpivirine.
Resource (Conference Presentation) updated 09/14/2023
Review of the SPNS demonstration site efforts to understand and integrate mental and behavioral health services and address the unmet needs of Black MSM.
Resource (Conference Presentation) updated 09/14/2023